Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-12-05
2010-06-22
Berch, Mark L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07741331
ABSTRACT:
Disclosed are novel A2Badenosine receptor antagonists having the structure of Formula I or Formula II:The compounds are particularly useful for treating asthma, inflammatory gastrointestinal tract disorders, cardiovascular diseases, neurological disorders, and diseases related to undesirable angiogenesis.
REFERENCES:
patent: 5776940 (1998-07-01), Daluge et al.
patent: 6117878 (2000-09-01), Linden
patent: 6825349 (2004-11-01), Kalla et al.
patent: 6894021 (2005-05-01), Belardinelli et al.
patent: 7304070 (2007-12-01), Kalla et al.
patent: 7317017 (2008-01-01), Kalla et al.
patent: 7579348 (2009-08-01), Wang et al.
patent: 2003/0207879 (2003-11-01), Baraldi et al.
patent: 2006/0293283 (2006-12-01), Kalla et al.
patent: 2007/0219221 (2007-09-01), Zeng et al.
patent: 2008/0153856 (2008-06-01), Kalla et al.
patent: 2008/0194593 (2008-08-01), Kalla et al.
patent: 2008/0318983 (2008-12-01), Kalla et al.
patent: 2009/0298744 (2009-12-01), Palle et al.
The MDAdvice.com entry for Asthma <http://www.mdadvice.com/topics/asthma/info/1.htm downloaded from the Internet Aug. 31, 2009.
Mazur, Farmatsevtichnii Zh. 1996 (3) 82-84.
Priimenko, Ukrainskii Khimicheskii Zh. 62(7-8) 121-124.
Klosa, Arch. Pharm. 1956 289, 211-217.
Elzein Elfatih
Ibrahim Prabha
Kalla Rao
Li Xiaofen
Palle Venkata
Berch Mark L
Gilead Palo Alto, Inc.
Hartrum J. Elin
LandOfFree
A2B adenosine receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A2B adenosine receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A2B adenosine receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4197908